Data Sheet

Quantify biodistribution, enhance in vivo decisions

Format: PDF file | Document type: Data Sheet | Promoted Content

This content is provided by Molecular Imaging Inc., and any views and opinions expressed do not necessarily reflect those of

Quantify biodistribution, enhance in vivo decisions

Non-invasive preclinical SPECT imaging of test agent biodistribution, kinetics and targeting in discovery and safety applications has key advantages over pre-existing methods including:

  • full 3-dimensionality with tissue and sub-tissue localization
  • fine kinetics, targeting, binding and clearance pathways can be examined
  • clinical translatability
  • isotope multiplexing to cost effectively address multiple questions simultaneously
  • SPECT isotope utility
    • longer half-lives improve study design and reduce quantity of tracer and animals
    • widely available, facilitating research goals

Related resources from Molecular Imaging Inc.

Supplier info centre